Hypertensive disorder of pregnancy is a common complication during pregnancy that affects approximately 10% of pregnancies and is responsible for nearly 14% of maternal deaths worldwide. It affects the mother and the fetus simultaneously, sometimes putting the health of the mother and the fetus at odds with each other. It...
A large number of new methods of measuring blood pressure (BP) have recently emerged with advances in technology. Different methods of measuring BP generally provide varying readings compared with one another. Clinicians must decide how to respond to these variations and how to assess the degree of agreement. Clinical agreement...
Burnout, Wellness and Systemic Change: A Clinician's Prescription for Well-Being Drs. Desiree Burroughs-Ray and Christopher Jackson REGISTER HERE This session will discuss system level and individual level practical solutions to healthcare workers dealing with burnout amidst the convergence of multiple pandemics. Using personal stories and changes enacted at the system...
Hypertension remains the leading modifiable risk factor for cardiovascular disease. Despite effective, safe, available, and affordable pharmacologic anti-hypertensive medications, the control rates of hypertension, defined as less than 140/90 mmHg, in the United States and globally remain dismal at approximately 45% and 20%, respectively. There are numerous barriers to achieving improved hypertension control which include patient, healthcare professional, and health system barriers.
Management of Hypertension : Time for Increased Patient Involvement Donald DiPette, MD, FACP, FAHA REGISTER HERE This webinar will focus on delineating patient-related barriers, addressing these barriers, and increasing the involvement of the patient in the management and treatment of their hypertension. The importance of educating the patient on the...
This program, HEARTS in America (HEARTS), is an initiative led by PAHO (Pan American Health Organization) and adapted for the United States, integrates seamlessly into existing cardiovascular and hypertension prevention and treatment programs. This training, delivered by HEARTS SMEs from across the globe, will focus on the pillars of HEARTS, critical drivers of hypertension, clinical pathways for standardized treatments while discussing the impacts of hypertension on diabetes and chronic kidney disease (CKD).
Objectives: Our principal objectives were to identify the level of adherence and identify the attitudes, beliefs, and behaviors that influence adherence to antihypertensive treatment among Vietnamese patients in New Orleans, Louisiana. Methods: By partnering with a community health center serving the Vietnamese community in New Orleans, we conducted reviews of...
Objectives: People with human immunodeficiency virus (HIV) are at an increased risk of developing cardiovascular diseases. Hypertensive emergency (HTNE), a complication of hypertension with potentially serious health implications, has high healthcare utilization. We attempted to determine the association between HIV status and risk for 30-day readmission after index hospitalization for...
This activity will review and discuss the important clinical implications of The 2021 WHO Guideline for the Pharmacological Treatment of Hypertension in the Adult.
Objective: To determine whether the introduction of hypertensive bundles through simulation and education would result in the timely assessment and treatment of a simulated patient in a peripartum hypertensive crisis. Methods: This prospective observational pilot study evaluates the use of simulation and education on hypertension bundled care for peripartum patients...
Membership grants access to journals, courses and a slew of premium benefits.
Please consider supporting us by choosing an option below:
View Membership Options Make A Tax-Deductable Donation
No Thanks, take me to the site and don't show me this again.